Johnson & Johnson to pay $5.5 billion settlement in talc cancer lawsuits
Johnson & Johnson has proposed a landmark settlement of approximately $5.5 billion to resolve around 76,000 lawsuits alleging that its talc products caused ovarian cancer. This settlement aims to conclude a contentious legal battle that has significantly impacted the company's reputation and finances.
Reports behind this story
Articles and publisher reports that informed this story.
Johnson & Johnson to pay $5.5bn settlement in talc cancer lawsuit
Landmark deal covers about 76,000 claims and could end contentious, decade-long legal battle Johnson Johnson said it would pay an estimated $5.5bn to resolve tens of thousands of lawsuits alleging its baby powder and other talc products caused ovarian cancer , in a landmark deal that could end a contentious, decade-long legal battle. Johnson Johnson on Monday said the settlement covers about 76,000 claims, including ones consolidated in a federal court in New Jersey, and related cases in state court, representing nearly all of the remaining talc claims against the company. Continue reading...
J&J offers $5.5bn to settle baby powder lawsuits
Johnson & Johnson (J&J) has offered to pay $5.5bn (£4.13bn) to resolve tens of thousands of lawsuits in the US alleging its talcum powder caused ovarian cancer. A bottle of Johnson and Johnson Baby Powder
Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits
The proposed settlement aims to close a years-long legal battle over claims its talcs products cause cancer.